vs
AMERICAN WOODMARK CORP(AMWD)与Apellis Pharmaceuticals, Inc.(APLS)财务数据对比。点击上方公司名可切换其他公司
AMERICAN WOODMARK CORP的季度营收约是Apellis Pharmaceuticals, Inc.的2.0倍($394.6M vs $199.9M),AMERICAN WOODMARK CORP净利率更高(1.5% vs -29.5%,领先31.0%),Apellis Pharmaceuticals, Inc.同比增速更快(-5.9% vs -12.8%),AMERICAN WOODMARK CORP自由现金流更多($638.0K vs $-14.3M),过去两年Apellis Pharmaceuticals, Inc.的营收复合增速更高(7.7% vs -3.3%)
美国木标公司是一家厨卫橱柜制造商,总部位于弗吉尼亚州温彻斯特。公司在美国多地设有多家生产基地与服务中心,其中生产基地分布在亚利桑那州、佐治亚州、印第安纳州、肯塔基州、马里兰州、田纳西州、弗吉尼亚州以及西弗吉尼亚州,服务网点覆盖全美各地。
Apellis Pharmaceuticals是一家临床阶段生物制药企业,专注于开发调节补体系统的靶向疗法,适应症覆盖年龄相关性黄斑变性继发地图样萎缩等眼科疾病、罕见血液病及自身免疫性疾病,核心市场为美国及欧盟地区。
AMWD vs APLS — 直观对比
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $394.6M | $199.9M |
| 净利润 | $6.1M | $-59.0M |
| 毛利率 | 15.2% | — |
| 营业利润率 | 3.1% | -25.6% |
| 净利率 | 1.5% | -29.5% |
| 营收同比 | -12.8% | -5.9% |
| 净利润同比 | -78.0% | -62.2% |
| 每股收益(稀释后) | $0.42 | $-0.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
| Q4 25 | $394.6M | $199.9M | ||
| Q3 25 | $403.0M | $458.6M | ||
| Q2 25 | $400.4M | $178.5M | ||
| Q1 25 | $397.6M | $166.8M | ||
| Q4 24 | $452.5M | $212.5M | ||
| Q3 24 | $459.1M | $196.8M | ||
| Q2 24 | $453.3M | $199.7M | ||
| Q1 24 | $422.1M | $172.3M |
| Q4 25 | $6.1M | $-59.0M | ||
| Q3 25 | $14.6M | $215.7M | ||
| Q2 25 | $25.6M | $-42.2M | ||
| Q1 25 | $16.6M | $-92.2M | ||
| Q4 24 | $27.7M | $-36.4M | ||
| Q3 24 | $29.6M | $-57.4M | ||
| Q2 24 | $26.8M | $-37.7M | ||
| Q1 24 | $21.2M | $-66.4M |
| Q4 25 | 15.2% | — | ||
| Q3 25 | 16.7% | — | ||
| Q2 25 | 17.0% | — | ||
| Q1 25 | 15.0% | — | ||
| Q4 24 | 18.9% | — | ||
| Q3 24 | 20.2% | — | ||
| Q2 24 | 18.6% | — | ||
| Q1 24 | 19.2% | — |
| Q4 25 | 3.1% | -25.6% | ||
| Q3 25 | 5.0% | 48.7% | ||
| Q2 25 | 7.4% | -18.6% | ||
| Q1 25 | 5.3% | -50.0% | ||
| Q4 24 | 9.4% | -12.3% | ||
| Q3 24 | 10.2% | -24.0% | ||
| Q2 24 | 8.4% | -14.7% | ||
| Q1 24 | 6.6% | -36.0% |
| Q4 25 | 1.5% | -29.5% | ||
| Q3 25 | 3.6% | 47.0% | ||
| Q2 25 | 6.4% | -23.6% | ||
| Q1 25 | 4.2% | -55.3% | ||
| Q4 24 | 6.1% | -17.1% | ||
| Q3 24 | 6.5% | -29.2% | ||
| Q2 24 | 5.9% | -18.9% | ||
| Q1 24 | 5.0% | -38.5% |
| Q4 25 | $0.42 | $-0.40 | ||
| Q3 25 | $1.00 | $1.67 | ||
| Q2 25 | $1.73 | $-0.33 | ||
| Q1 25 | $1.09 | $-0.74 | ||
| Q4 24 | $1.79 | $-0.30 | ||
| Q3 24 | $1.89 | $-0.46 | ||
| Q2 24 | $1.70 | $-0.30 | ||
| Q1 24 | $1.32 | $-0.54 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $52.1M | $466.2M |
| 总债务越低越好 | $363.3M | — |
| 股东权益账面价值 | $928.2M | $370.1M |
| 总资产 | $1.6B | $1.1B |
| 负债/权益比越低杠杆越低 | 0.39× | — |
8季度趋势,按日历期对齐
| Q4 25 | $52.1M | $466.2M | ||
| Q3 25 | $54.9M | $479.2M | ||
| Q2 25 | $48.2M | $370.0M | ||
| Q1 25 | $43.5M | $358.4M | ||
| Q4 24 | $56.7M | $411.3M | ||
| Q3 24 | $89.3M | $396.9M | ||
| Q2 24 | $87.4M | $360.1M | ||
| Q1 24 | $97.8M | $325.9M |
| Q4 25 | $363.3M | — | ||
| Q3 25 | $364.8M | — | ||
| Q2 25 | $365.8M | — | ||
| Q1 25 | $367.3M | — | ||
| Q4 24 | $368.0M | — | ||
| Q3 24 | $372.2M | — | ||
| Q2 24 | $371.8M | — | ||
| Q1 24 | $371.3M | $93.1M |
| Q4 25 | $928.2M | $370.1M | ||
| Q3 25 | $920.3M | $401.2M | ||
| Q2 25 | $916.0M | $156.3M | ||
| Q1 25 | $919.6M | $164.2M | ||
| Q4 24 | $915.1M | $228.5M | ||
| Q3 24 | $913.8M | $237.1M | ||
| Q2 24 | $910.4M | $264.3M | ||
| Q1 24 | $896.9M | $266.7M |
| Q4 25 | $1.6B | $1.1B | ||
| Q3 25 | $1.6B | $1.1B | ||
| Q2 25 | $1.6B | $821.4M | ||
| Q1 25 | $1.6B | $807.3M | ||
| Q4 24 | $1.6B | $885.1M | ||
| Q3 24 | $1.6B | $901.9M | ||
| Q2 24 | $1.6B | $904.5M | ||
| Q1 24 | $1.6B | $831.9M |
| Q4 25 | 0.39× | — | ||
| Q3 25 | 0.40× | — | ||
| Q2 25 | 0.40× | — | ||
| Q1 25 | 0.40× | — | ||
| Q4 24 | 0.40× | — | ||
| Q3 24 | 0.41× | — | ||
| Q2 24 | 0.41× | — | ||
| Q1 24 | 0.41× | 0.35× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $11.2M | $-14.2M |
| 自由现金流经营现金流 - 资本支出 | $638.0K | $-14.3M |
| 自由现金流率自由现金流/营收 | 0.2% | -7.1% |
| 资本支出强度资本支出/营收 | 2.7% | 0.1% |
| 现金转化率经营现金流/净利润 | 1.83× | — |
| 过去12个月自由现金流最近4个季度 | $64.0M | $45.0M |
8季度趋势,按日历期对齐
| Q4 25 | $11.2M | $-14.2M | ||
| Q3 25 | $33.1M | $108.5M | ||
| Q2 25 | $44.8M | $4.4M | ||
| Q1 25 | $11.0M | $-53.4M | ||
| Q4 24 | $11.9M | $19.4M | ||
| Q3 24 | $40.8M | $34.1M | ||
| Q2 24 | $43.3M | $-8.3M | ||
| Q1 24 | $43.7M | $-133.0M |
| Q4 25 | $638.0K | $-14.3M | ||
| Q3 25 | $25.3M | $108.3M | ||
| Q2 25 | $35.8M | $4.4M | ||
| Q1 25 | $2.3M | $-53.4M | ||
| Q4 24 | $1.1M | $19.3M | ||
| Q3 24 | $29.5M | — | ||
| Q2 24 | $7.2M | $-8.4M | ||
| Q1 24 | $22.1M | $-133.3M |
| Q4 25 | 0.2% | -7.1% | ||
| Q3 25 | 6.3% | 23.6% | ||
| Q2 25 | 8.9% | 2.5% | ||
| Q1 25 | 0.6% | -32.0% | ||
| Q4 24 | 0.2% | 9.1% | ||
| Q3 24 | 6.4% | — | ||
| Q2 24 | 1.6% | -4.2% | ||
| Q1 24 | 5.2% | -77.3% |
| Q4 25 | 2.7% | 0.1% | ||
| Q3 25 | 1.9% | 0.0% | ||
| Q2 25 | 2.2% | 0.0% | ||
| Q1 25 | 2.2% | 0.0% | ||
| Q4 24 | 2.4% | 0.0% | ||
| Q3 24 | 2.5% | 0.0% | ||
| Q2 24 | 8.0% | 0.0% | ||
| Q1 24 | 5.1% | 0.2% |
| Q4 25 | 1.83× | — | ||
| Q3 25 | 2.27× | 0.50× | ||
| Q2 25 | 1.75× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.43× | — | ||
| Q3 24 | 1.38× | — | ||
| Q2 24 | 1.62× | — | ||
| Q1 24 | 2.06× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMWD
| Home Center Retailers | $166.7M | 42% |
| Builders | $164.7M | 42% |
| Independent Dealersand Distributors | $63.2M | 16% |
APLS
| Syfovre | $155.2M | 78% |
| Empaveli Pegcetacoplan | $35.1M | 18% |
| Licensing And Other Revenue | $9.6M | 5% |